Survival after trimodality treatment for superior sulcus and central t4 non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 4, Issue 1, 2009, Pages 62-68

  De Leyn, Paul ^a,b   Vansteenkiste, Johan ^a   Lievens, Yolande ^a   Van Raemdonck, Dirk ^a   Nafteux, Philippe ^a   Decker, Georges ^a   Coosemans, Willy ^a   Decaluwé, Herbert ^a   Moons, Johny ^a   Lerut, Tony ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Department of Thoracic Surgery ^*  (Belgium)

Author keywords

Induction therapy; Lung cancer; Superior sulcus; T4; Trimodality treatment

Indexed keywords

CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; THORAX WALL; TREATMENT RESPONSE; ADENOCARCINOMA; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEASIBILITY STUDY; LARGE CELL CARCINOMA; LUNG TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; REMISSION; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61549140422     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181914d52     Document Type: Article

References (29)

1. Shaw R, Paulson D, Kee J. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961;7:29-40.
2. Paulson D. Carcinomas in the superior pulmonary sulcus. J Thorac Cardiovasc Surg 1975;70:1095-1105.
3. Rusch V, Parekh K, Leon L, et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg 2000;119:1147-1153.
4. Tsuchiya R, Asamura H, Kondo H, Goya T, Naruke T. Extended resection of the left atrium, great vessels, or both for lung cancer. Ann Thorac Surg 1994;57:960-965.
5. Rusch V, Giroux D, Kraut M, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group trial 9416 (Inter-group trial 0160). J Thorac Cardiovasc Surg 2001;121:472-483.
6. Albain K, Rusch V, Crowley J, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of southwest oncology group phase II study 8805. J Clin Oncol 1995;13:1880-1892.
7. Albain K, Rusch V, Crowley J, et al. Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky stages IIIA(N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group study 8805. Proc ASCO 1999;18:467A.
8. Detterbeck F. Changes in the treatment of pancoast tumours. Ann Thorac Surg 2003;75:1990-1997.
9. Senan S, De Ruysscher D, Giraud P, Mirimanoff R, Budach V; Radiotherapy Group of European Organization for Research and Treatment of Cancer. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 2004;71:139-146.
10. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-216.
11. Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-792.
12. Grunenwald D, Spaggiari L. Transmanubrial osteomuscular sparing approach for apical chest tumors. Ann Thorac Surg 1997;63:563-566.
13. Martini N, Yellin A, Ginsberg R, et al. Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg 1994;58:1447-1451.
14. Rusch V, Giroux D, Kraut M, et al. Induction chemoradiation and surgical resection for superior sulcus non-small cell lung carcinomas: long-term results of Southwest Oncology group trial 9416 (Intergroup trial 0160). J Clin Oncol 2007;25:313-318.
15. Kunitoh H, Kato H, Tsuboi M, et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small cell lung cancers: report of Japan clinical oncology group trial 9806. J Clin Oncol 2008;26:644-649.
16. Marra A, Eberhardt W, Pöttgen C, et al. Induction chemotherapy, concurrent chemoradiation and surgery for pancoast tumour. Eur Respir J 2007;29:117-127.
17. Rendina E, Venuta F, De Giacomo T, et al. Induction chemotherapy for T4 centrally located non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:225-233.
18. Vora S, Daly B, Blaszkowsky L, et al. High dose radiation therapy and chemotherapy as induction treatment for stage III non-small cell lung carcinoma. Cancer 2000;89:1946-1952.
19. Albain K, Crowley J, Turrisi A, et al. Concurrent cisplatin, etoposide and chest radiotherapy in pathologic stage IIIB non-small cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 2002;20:3454-3460.
20. Verhagen AT, Bootsma GP, Tjan-Heijnen VCG, et al. FDG-PET in staging lung cancer. How does it change the algorithm? Lung Cancer 2004;44:175-181.
21. Alberts W; American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:1-19.
22. Albain K, Swann R, Rusch V, et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309). J Clin Oncol 2005;23:7014.
23. Martin J, Ginsberg RJ, Devore R, et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 2001;72:1149-1154.
24. Pourel N, Santelmo N, Naafa N, et al. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Eur J Cardiothorac Surg 2008;33: 829-836.
25. Eberhardt W, Wilke H, Stamatis G, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfraction-ated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: mature results of a phase II trial. J Clin Oncol 1998;16:622-634.
26. Ginsberg R, Martini N, Zaman M, et al. Influence of surgical resection and brachytherapy in the management of superior sulcus tumour. Ann Thorac Surg 1994;57:1440-1445.
27. Kwong K, Edelman M, Suntharalingam M, et al. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival. J Thorac Cardiovasc Surg 2005;129:1250-1257.
28. Pöttgen C, Eberhardt W, Grannass A, et al. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. J Clin Oncol 2007;25:4987-4992.
29. Little AG, Ferguson MK. Pericardioscopy as adjunct to pericardial window. Chest 1986;89:53-55.